메뉴 건너뛰기




Volumn 111, Issue 8 SUPPL., 2013, Pages 10C-15C

Managing pulmonary arterial hypertension and optimizing treatment options: Prognosis of pulmonary artery hypertension

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROSTACYCLIN;

EID: 84875897211     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.01.319     Document Type: Article
Times cited : (18)

References (30)
  • 2
    • 0025837793 scopus 로고
    • Survival in patients with primary pulmonary hypertension. Results from a national prospective registry
    • G.E. D'Alonzo, R.J. Barst, and S.M. Ayres Survival in patients with primary pulmonary hypertension. Results from a national prospective registry Ann Intern Med 115 1991 343 349
    • (1991) Ann Intern Med , vol.115 , pp. 343-349
    • D'Alonzo, G.E.1    Barst, R.J.2    Ayres, S.M.3
  • 5
    • 0037126044 scopus 로고    scopus 로고
    • Survival in primary pulmonary hypertension: The impact of epoprostenol therapy
    • V.V. McLaughlin, A. Shillington, and S. Rich Survival in primary pulmonary hypertension: the impact of epoprostenol therapy Circulation 106 2002 1477 1482
    • (2002) Circulation , vol.106 , pp. 1477-1482
    • McLaughlin, V.V.1    Shillington, A.2    Rich, S.3
  • 9
    • 0024359577 scopus 로고
    • Two-dimensional and Doppler echocardiography and cardiac catheterisation correlates of survival in primary pulmonary hypertension
    • S.B. Eysmann, H.I. Palevsky, N. Reichek, K. Hackney, and P.S. Douglas Two-dimensional and Doppler echocardiography and cardiac catheterisation correlates of survival in primary pulmonary hypertension Circulation 80 1989 353 360
    • (1989) Circulation , vol.80 , pp. 353-360
    • Eysmann, S.B.1    Palevsky, H.I.2    Reichek, N.3    Hackney, K.4    Douglas, P.S.5
  • 12
    • 17144452791 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension
    • N. Nagaya, T. Nishikimi, and Y. Okano Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension J Am Coll Cardiol 31 1998 202 208
    • (1998) J Am Coll Cardiol , vol.31 , pp. 202-208
    • Nagaya, N.1    Nishikimi, T.2    Okano, Y.3
  • 13
    • 16644368513 scopus 로고    scopus 로고
    • Usefulness of B-type natriuertic peptide as a predictor of treatment outcome in pulmonary arterial hypertension
    • M.H. Park, R.L. Scott, P.A. Uber, H.O. Ventura, and M.R. Mehra Usefulness of B-type natriuertic peptide as a predictor of treatment outcome in pulmonary arterial hypertension Congest Heart Fail 10 2004 221 225
    • (2004) Congest Heart Fail , vol.10 , pp. 221-225
    • Park, M.H.1    Scott, R.L.2    Uber, P.A.3    Ventura, H.O.4    Mehra, M.R.5
  • 14
    • 33646476400 scopus 로고    scopus 로고
    • Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension
    • A. Fijalkowska, M. Kurzyna, A. Torbicki, G. Szewczyk, M. Florczyk, P. Pruszczyk, and M. Szturmowicz Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension Chest 129 2006 1313 1321
    • (2006) Chest , vol.129 , pp. 1313-1321
    • Fijalkowska, A.1    Kurzyna, M.2    Torbicki, A.3    Szewczyk, G.4    Florczyk, M.5    Pruszczyk, P.6    Szturmowicz, M.7
  • 18
    • 3142777629 scopus 로고    scopus 로고
    • Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines
    • American College of Chest Physicians
    • V.V. McLaughlin, K.W. Presberg, R.L. Doyle, S.H. Abman, D.C. McCrory, T. Fortin, G. Ahearn American College of Chest Physicians Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines Chest 126 2004 78S 92S
    • (2004) Chest , vol.126
    • McLaughlin, V.V.1    Presberg, K.W.2    Doyle, R.L.3    Abman, S.H.4    McCrory, D.C.5    Fortin, T.6    Ahearn, G.7
  • 21
    • 74549213864 scopus 로고    scopus 로고
    • Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension
    • K. Dimopoulos, R. Inuzuka, S. Goletto, G. Giannakoulas, L. Swan, S.J. Wort, and M.A. Gatzoulis Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension Circulation 121 2010 20 25
    • (2010) Circulation , vol.121 , pp. 20-25
    • Dimopoulos, K.1    Inuzuka, R.2    Goletto, S.3    Giannakoulas, G.4    Swan, L.5    Wort, S.J.6    Gatzoulis, M.A.7
  • 22
    • 84857856069 scopus 로고    scopus 로고
    • The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension
    • N. Nickel, H. Golpon, M. Greer, L. Knudsen, K. Olsson, V. Westerkamp, T. Welte, and M.M. Hoeper The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension Eur Respir J 39 2012 589 596
    • (2012) Eur Respir J , vol.39 , pp. 589-596
    • Nickel, N.1    Golpon, H.2    Greer, M.3    Knudsen, L.4    Olsson, K.5    Westerkamp, V.6    Welte, T.7    Hoeper, M.M.8
  • 24
    • 70349412797 scopus 로고    scopus 로고
    • Optimal use of spironolactone for treatment of heart failure
    • K.M. Parker, N. Houston Miller, and R.F. DeBusk Optimal use of spironolactone for treatment of heart failure Congest Heart Fail 7 2001 315 318
    • (2001) Congest Heart Fail , vol.7 , pp. 315-318
    • Parker, K.M.1    Houston Miller, N.2    Debusk, R.F.3
  • 26
  • 27
    • 64849109410 scopus 로고    scopus 로고
    • ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; And the Pulmonary Hypertension Association
    • American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association
    • V.V. McLaughlin, S.L. Archer, D.B. Badesch, R.J. Barst, H.W. Farber, J.R. Lindner, M.A. Mathier, M.D. McGoon, M.H. Park, R.S. Rosenson, L.J. Rubin, V.F. Tapson, J. Varga American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association J Am Coll Cardiol 53 2009 1573 1619
    • (2009) J Am Coll Cardiol , vol.53 , pp. 1573-1619
    • McLaughlin, V.V.1    Archer, S.L.2    Badesch, D.B.3    Barst, R.J.4    Farber, H.W.5    Lindner, J.R.6    Mathier, M.A.7    McGoon, M.D.8    Park, M.H.9    Rosenson, R.S.10    Rubin, L.J.11    Tapson, V.F.12    Varga, J.13
  • 29
    • 27744504402 scopus 로고    scopus 로고
    • Goal-oriented treatment and combination therapy for pulmonary arterial hypertension
    • M.M. Hoeper, I. Markevych, E. Spiekerkoetter, T. Welte, and J. Niedermeyer Goal-oriented treatment and combination therapy for pulmonary arterial hypertension Eur Respir J 26 2005 858 863
    • (2005) Eur Respir J , vol.26 , pp. 858-863
    • Hoeper, M.M.1    Markevych, I.2    Spiekerkoetter, E.3    Welte, T.4    Niedermeyer, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.